List of Chapters/Sections(Table Of Content)
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Postoperative Nausea and Vomiting (PONV) Market Size Analysis from 2023 to 2028
1.5.1 Global Postoperative Nausea and Vomiting (PONV) Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Postoperative Nausea and Vomiting (PONV) Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Postoperative Nausea and Vomiting (PONV) Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Postoperative Nausea and Vomiting (PONV) Industry Impact
Chapter 2 Global Postoperative Nausea and Vomiting (PONV) Competition by Types, Applications, and Top Regions and Countries
2.1 Global Postoperative Nausea and Vomiting (PONV) (Volume and Value) by Type
2.1.1 Global Postoperative Nausea and Vomiting (PONV) Consumption and Market Share by Type (2017-2022)
2.1.2 Global Postoperative Nausea and Vomiting (PONV) Revenue and Market Share by Type (2017-2022)
2.2 Global Postoperative Nausea and Vomiting (PONV) (Volume and Value) by Application
2.2.1 Global Postoperative Nausea and Vomiting (PONV) Consumption and Market Share by Application (2017-2022)
2.2.2 Global Postoperative Nausea and Vomiting (PONV) Revenue and Market Share by Application (2017-2022)
2.3 Global Postoperative Nausea and Vomiting (PONV) (Volume and Value) by Regions
2.3.1 Global Postoperative Nausea and Vomiting (PONV) Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Postoperative Nausea and Vomiting (PONV) Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Postoperative Nausea and Vomiting (PONV) Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Postoperative Nausea and Vomiting (PONV) Consumption by Regions (2017-2022)
4.2 North America Postoperative Nausea and Vomiting (PONV) Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Postoperative Nausea and Vomiting (PONV) Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Postoperative Nausea and Vomiting (PONV) Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Postoperative Nausea and Vomiting (PONV) Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Postoperative Nausea and Vomiting (PONV) Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Postoperative Nausea and Vomiting (PONV) Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Postoperative Nausea and Vomiting (PONV) Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Postoperative Nausea and Vomiting (PONV) Sales, Consumption, Export, Import (2017-2022)
4.10 South America Postoperative Nausea and Vomiting (PONV) Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Postoperative Nausea and Vomiting (PONV) Market Analysis
5.1 North America Postoperative Nausea and Vomiting (PONV) Consumption and Value Analysis
5.1.1 North America Postoperative Nausea and Vomiting (PONV) Market Under COVID-19
5.2 North America Postoperative Nausea and Vomiting (PONV) Consumption Volume by Types
5.3 North America Postoperative Nausea and Vomiting (PONV) Consumption Structure by Application
5.4 North America Postoperative Nausea and Vomiting (PONV) Consumption by Top Countries
5.4.1 United States Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
5.4.2 Canada Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
5.4.3 Mexico Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
Chapter 6 East Asia Postoperative Nausea and Vomiting (PONV) Market Analysis
6.1 East Asia Postoperative Nausea and Vomiting (PONV) Consumption and Value Analysis
6.1.1 East Asia Postoperative Nausea and Vomiting (PONV) Market Under COVID-19
6.2 East Asia Postoperative Nausea and Vomiting (PONV) Consumption Volume by Types
6.3 East Asia Postoperative Nausea and Vomiting (PONV) Consumption Structure by Application
6.4 East Asia Postoperative Nausea and Vomiting (PONV) Consumption by Top Countries
6.4.1 China Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
6.4.2 Japan Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
6.4.3 South Korea Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
Chapter 7 Europe Postoperative Nausea and Vomiting (PONV) Market Analysis
7.1 Europe Postoperative Nausea and Vomiting (PONV) Consumption and Value Analysis
7.1.1 Europe Postoperative Nausea and Vomiting (PONV) Market Under COVID-19
7.2 Europe Postoperative Nausea and Vomiting (PONV) Consumption Volume by Types
7.3 Europe Postoperative Nausea and Vomiting (PONV) Consumption Structure by Application
7.4 Europe Postoperative Nausea and Vomiting (PONV) Consumption by Top Countries
7.4.1 Germany Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
7.4.2 UK Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
7.4.3 France Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
7.4.4 Italy Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
7.4.5 Russia Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
7.4.6 Spain Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
7.4.7 Netherlands Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
7.4.8 Switzerland Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
7.4.9 Poland Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
Chapter 8 South Asia Postoperative Nausea and Vomiting (PONV) Market Analysis
8.1 South Asia Postoperative Nausea and Vomiting (PONV) Consumption and Value Analysis
8.1.1 South Asia Postoperative Nausea and Vomiting (PONV) Market Under COVID-19
8.2 South Asia Postoperative Nausea and Vomiting (PONV) Consumption Volume by Types
8.3 South Asia Postoperative Nausea and Vomiting (PONV) Consumption Structure by Application
8.4 South Asia Postoperative Nausea and Vomiting (PONV) Consumption by Top Countries
8.4.1 India Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
8.4.2 Pakistan Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Postoperative Nausea and Vomiting (PONV) Market Analysis
9.1 Southeast Asia Postoperative Nausea and Vomiting (PONV) Consumption and Value Analysis
9.1.1 Southeast Asia Postoperative Nausea and Vomiting (PONV) Market Under COVID-19
9.2 Southeast Asia Postoperative Nausea and Vomiting (PONV) Consumption Volume by Types
9.3 Southeast Asia Postoperative Nausea and Vomiting (PONV) Consumption Structure by Application
9.4 Southeast Asia Postoperative Nausea and Vomiting (PONV) Consumption by Top Countries
9.4.1 Indonesia Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
9.4.2 Thailand Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
9.4.3 Singapore Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
9.4.4 Malaysia Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
9.4.5 Philippines Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
9.4.6 Vietnam Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
9.4.7 Myanmar Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
Chapter 10 Middle East Postoperative Nausea and Vomiting (PONV) Market Analysis
10.1 Middle East Postoperative Nausea and Vomiting (PONV) Consumption and Value Analysis
10.1.1 Middle East Postoperative Nausea and Vomiting (PONV) Market Under COVID-19
10.2 Middle East Postoperative Nausea and Vomiting (PONV) Consumption Volume by Types
10.3 Middle East Postoperative Nausea and Vomiting (PONV) Consumption Structure by Application
10.4 Middle East Postoperative Nausea and Vomiting (PONV) Consumption by Top Countries
10.4.1 Turkey Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
10.4.3 Iran Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
10.4.5 Israel Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
10.4.6 Iraq Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
10.4.7 Qatar Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
10.4.8 Kuwait Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
10.4.9 Oman Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
Chapter 11 Africa Postoperative Nausea and Vomiting (PONV) Market Analysis
11.1 Africa Postoperative Nausea and Vomiting (PONV) Consumption and Value Analysis
11.1.1 Africa Postoperative Nausea and Vomiting (PONV) Market Under COVID-19
11.2 Africa Postoperative Nausea and Vomiting (PONV) Consumption Volume by Types
11.3 Africa Postoperative Nausea and Vomiting (PONV) Consumption Structure by Application
11.4 Africa Postoperative Nausea and Vomiting (PONV) Consumption by Top Countries
11.4.1 Nigeria Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
11.4.2 South Africa Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
11.4.3 Egypt Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
11.4.4 Algeria Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
11.4.5 Morocco Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
Chapter 12 Oceania Postoperative Nausea and Vomiting (PONV) Market Analysis
12.1 Oceania Postoperative Nausea and Vomiting (PONV) Consumption and Value Analysis
12.2 Oceania Postoperative Nausea and Vomiting (PONV) Consumption Volume by Types
12.3 Oceania Postoperative Nausea and Vomiting (PONV) Consumption Structure by Application
12.4 Oceania Postoperative Nausea and Vomiting (PONV) Consumption by Top Countries
12.4.1 Australia Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
12.4.2 New Zealand Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
Chapter 13 South America Postoperative Nausea and Vomiting (PONV) Market Analysis
13.1 South America Postoperative Nausea and Vomiting (PONV) Consumption and Value Analysis
13.1.1 South America Postoperative Nausea and Vomiting (PONV) Market Under COVID-19
13.2 South America Postoperative Nausea and Vomiting (PONV) Consumption Volume by Types
13.3 South America Postoperative Nausea and Vomiting (PONV) Consumption Structure by Application
13.4 South America Postoperative Nausea and Vomiting (PONV) Consumption Volume by Major Countries
13.4.1 Brazil Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
13.4.2 Argentina Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
13.4.3 Columbia Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
13.4.4 Chile Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
13.4.5 Venezuela Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
13.4.6 Peru Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
13.4.8 Ecuador Postoperative Nausea and Vomiting (PONV) Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Postoperative Nausea and Vomiting (PONV) Business
14.1 Acacia Pharma
14.1.1 Acacia Pharma Company Profile
14.1.2 Acacia Pharma Postoperative Nausea and Vomiting (PONV) Product Specification
14.1.3 Acacia Pharma Postoperative Nausea and Vomiting (PONV) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 F. Hoffmann-La Roche
14.2.1 F. Hoffmann-La Roche Company Profile
14.2.2 F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Product Specification
14.2.3 F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Novartis
14.3.1 Novartis Company Profile
14.3.2 Novartis Postoperative Nausea and Vomiting (PONV) Product Specification
14.3.3 Novartis Postoperative Nausea and Vomiting (PONV) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Ani Pharmaceuticals
14.4.1 Ani Pharmaceuticals Company Profile
14.4.2 Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Product Specification
14.4.3 Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Camurus
14.5.1 Camurus Company Profile
14.5.2 Camurus Postoperative Nausea and Vomiting (PONV) Product Specification
14.5.3 Camurus Postoperative Nausea and Vomiting (PONV) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Sanofi
14.6.1 Sanofi Company Profile
14.6.2 Sanofi Postoperative Nausea and Vomiting (PONV) Product Specification
14.6.3 Sanofi Postoperative Nausea and Vomiting (PONV) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Helsinn Holding
14.7.1 Helsinn Holding Company Profile
14.7.2 Helsinn Holding Postoperative Nausea and Vomiting (PONV) Product Specification
14.7.3 Helsinn Holding Postoperative Nausea and Vomiting (PONV) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Eisai
14.8.1 Eisai Company Profile
14.8.2 Eisai Postoperative Nausea and Vomiting (PONV) Product Specification
14.8.3 Eisai Postoperative Nausea and Vomiting (PONV) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 Merck
14.9.1 Merck Company Profile
14.9.2 Merck Postoperative Nausea and Vomiting (PONV) Product Specification
14.9.3 Merck Postoperative Nausea and Vomiting (PONV) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 GlaxoSmithKline
14.10.1 GlaxoSmithKline Company Profile
14.10.2 GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Product Specification
14.10.3 GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Postoperative Nausea and Vomiting (PONV) Market Forecast (2023-2028)
15.1 Global Postoperative Nausea and Vomiting (PONV) Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Postoperative Nausea and Vomiting (PONV) Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Postoperative Nausea and Vomiting (PONV) Value and Growth Rate Forecast (2023-2028)
15.2 Global Postoperative Nausea and Vomiting (PONV) Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Postoperative Nausea and Vomiting (PONV) Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Postoperative Nausea and Vomiting (PONV) Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Postoperative Nausea and Vomiting (PONV) Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Postoperative Nausea and Vomiting (PONV) Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Postoperative Nausea and Vomiting (PONV) Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Postoperative Nausea and Vomiting (PONV) Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Postoperative Nausea and Vomiting (PONV) Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Postoperative Nausea and Vomiting (PONV) Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Postoperative Nausea and Vomiting (PONV) Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Postoperative Nausea and Vomiting (PONV) Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Postoperative Nausea and Vomiting (PONV) Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Postoperative Nausea and Vomiting (PONV) Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Postoperative Nausea and Vomiting (PONV) Consumption Forecast by Type (2023-2028)
15.3.2 Global Postoperative Nausea and Vomiting (PONV) Revenue Forecast by Type (2023-2028)
15.3.3 Global Postoperative Nausea and Vomiting (PONV) Price Forecast by Type (2023-2028)
15.4 Global Postoperative Nausea and Vomiting (PONV) Consumption Volume Forecast by Application (2023-2028)
15.5 Postoperative Nausea and Vomiting (PONV) Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
